PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
Auto Draft
Auto Draft
Auto Draft
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

How AI Is Transforming Microbial Ingredient Production

Population growth, shrinking arable land and climate change are intensifying pressure on global food systems.
Microorganism-based ingredients offer a compelling alternative; many fungi, yeasts and microalgae contain
50–70% protein by dry weight, and modern metabolic engineering now enables microbes to produce specialised
food proteins. Fermentation already underpins the production of vitamins, flavours, sweeteners, pigments,
enzymes and cosmetic actives, while oleaginous microbes provide sustainable routes to edible and functional oils. Recent advances in synthetic biology and multi-omics have made microbial platforms more predictable and versatile. Yet major challenges remain in discovering the right ingredients, engineering efficient production pathways and ensuring quality at scale. This article explores how artificial intelligence (AI) can accelerate these steps from ingredient discovery to bioprocess optimisation.

Ingredient Innovation Through AI-Driven Biotechnology:
Revolutionising Sourcing and Yield Optimisation
AI-driven approaches tackle ingredient innovation through
three complementary strategies:

  1. Screening natural microbial diversity to identify organisms
    that naturally produce compounds of interest.
  2. Enzymatic engineering for optimising catalytic processes
    and discovering novel enzymes.
  3. Metabolic pathway engineering for creating entirely new
    biosynthetic routes through microbial cell factories.
    Together, these methodologies are reshaping how industries
    think about ingredient sourcing, moving from synthetic chemistry
    to synthetic biology.

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC